Seagen Inc. - Common Stock (NQ:SGEN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Seagen Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 09, 2022

Gainers Bone Biologics (NASDAQ:BBLG) shar...

Via Benzinga

Recap: Seagen Q4 Earnings ↗

February 09, 2022

Seagen (NASDAQ:SGEN) reported its Q4 earnings results on Wednesday, February 9, 2022 at 04:02 PM. Here's what investors need to know about the announcement. Earnings Seagen missed estimated earnings by...

Via Benzinga

Seagen Reports Fourth Quarter and Full Year 2021 Financial Results

February 09, 2022

From Seagen Inc.

Via Business Wire

The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In ↗

February 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For February 9, 2022 ↗

February 09, 2022

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion.

Via Benzinga

Where Seagen Stands With Analysts ↗

January 18, 2022

Within the last quarter, Seagen (NASDAQ:SGEN) has observed the following analy...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 18, 2022

Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...

Via Benzinga

Seagen to Present at the 11th Annual SVB Leerink Global Healthcare Conference

February 08, 2022

From Seagen Inc.

Via Business Wire

A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls Over 1% ↗

February 07, 2022

Pre-open movers

Via Benzinga

ADCETRIS® Combination Significantly Improves Overall Survival in Newly Diagnosed Patients with Advanced Hodgkin Lymphoma

February 03, 2022

From Seagen Inc.

Via Business Wire

Seagen Publishes Inaugural Corporate Responsibility Report

December 07, 2021

SOURCE: Seagen

Via 3BL Media

Topics Emissions

Where Seagen Stands With Analysts ↗

November 09, 2021

Over the past 3 months, 6 analysts have published their opinion on Seagen (NASDAQ:

Via Benzinga

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

Seagen Appoints Lee Heeson as Executive Vice President, Commercial International

February 01, 2022

From Seagen Inc.

Via Business Wire

Groundbreaking Clinical Trials Accelerating New Treatment Options for Pancreatic Cancer

February 02, 2022

Palm Beach, FL – February 2, 2022 – FinancialNewsMedia.com News Commentary – In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical. These trials...

Via FinancialNewsMedia

Will Chart Analysts Notice Bad Omen on Seagen's Chart ↗

January 21, 2022

If history is any guide, there may be trouble ahead for shares of Seagen (NASDAQ:SGEN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...

Via Benzinga

Seagen's SEA-CD40 Combo Regime Shows Preliminary Antitumor Activity In Pancreatic Cancer ↗

January 19, 2022

Seagen Inc (NASDAQ: SGEN) announced data from a Phase 1 trial combining SEA-CD40 with chemotherapy and an anti-PD-1 in patients with metastatic pancreatic ductal...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022 ↗

January 31, 2022

Upgrades UBS upgraded the previous rating for Align Technology Inc (NASDAQ:ALGN) from Neutral to Buy. For the third quarter, Align Tech had an EPS of $2.87, compared to year-ago...

Via Benzinga

Seagen Reports Data From SEA-CD40 in Combination With Other Therapies in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI)

January 18, 2022

From Seagen Inc.

Via Business Wire

Seagen to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2021 Financial Results on February 9, 2022

January 18, 2022

From Seagen Inc.

Via Business Wire

5 Stocks Insiders Are Selling ↗

January 06, 2022

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...

Via Benzinga

Seagen to Present at the J.P. Morgan Healthcare Conference

December 20, 2021

From Seagen Inc.

Via Business Wire

Astellas and Seagen Receive Positive CHMP Opinion for PADCEV™ (enfortumab vedotin) in Locally Advanced or Metastatic Urothelial Cancer

December 17, 2021

From Seagen Inc.

Via Business Wire

Seagen Announces Preliminary Results from Phase 2 Clinical Trial of ADCETRIS® (brentuximab vedotin) in Novel Combination of Agents for Patients with Advanced Stage Classical Hodgkin Lymphoma

December 12, 2021

From Seagen Inc.

Via Business Wire

Seagen Tukysa Maintains Survival Benefit, Delays Cancer Progression In The Brain In Breast Cancer Patients ↗

December 09, 2021

Seagen Inc (NASDAQ: SGEN) has revealed new data from exploratory analyses from the HER2CLIMB trial of Tukysa (tucatinib) combined with trastuzumab &...

Via Benzinga

Seagen Announces Updated Results from Pivotal HER2CLIMB Trial Evaluating TUKYSA® (tucatinib) in Patients with HER2-Positive Breast Cancer with Brain Metastases

December 08, 2021

From Seagen Inc.

Via Business Wire

Why This Investor Is Selling His Seagen Shares ↗

December 06, 2021

Having fallen more than 22% over the last month, Seagen Inc (NASDAQ: SGEN) shares are now trading down about 15% year-to-date. With Seagen stock seemingly stuck in a downtrend,...

Via Benzinga

5 Stocks Insiders Are Selling ↗

December 03, 2021

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...

Via Benzinga

Investing $100,000 Into These 2 Stocks 10 Years Ago Would Have Made You a Millionaire Today ↗

November 22, 2021

And doing so wouldn't have involved gambling with your portfolio, either.

Via The Motley Fool

Seagen to Highlight New Data in Advanced Breast Cancer at 2021 San Antonio Breast Cancer Symposium

November 19, 2021

From Seagen, Inc.

Via Business Wire

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.